This week I saw a patient about to start chemotherapy for breast cancer. She was deciding whether to take a drug that would reduce her recurrence risk by 50%, or the more aggressive regimen recommended by her oncologist, which would reduce her risk by another 6% but carries the risk of additional longlasting side effects.1… Read More »
- « Previous Page
- 1
- …
- 8
- 9
- 10